Spravato is an FDA-approved prescription nasal spray that contains esketamine. It is used as an advanced treatment option for individuals with depression who have not responded well to traditional antidepressant medications.
At The Neuropsychiatry & TMS Group, Spravato therapy is offered as part of a comprehensive approach to treating depression, particularly for those experiencing treatment-resistant symptoms. Treatment is administered in a controlled clinical setting under medical supervision to ensure safety and appropriate monitoring. By offering Spravato alongside other evidence-based services, the team is able to tailor care plans to each individual’s needs and treatment history.
Spravato therapy may be an option to consider if depression symptoms continue to affect your daily life despite trying traditional antidepressants. It is FDA-approved for major depressive disorder and is often used when symptoms have not responded adequately to medication.
Spravato may be a good fit for people who are experiencing:
At The Neuropsychiatry & TMS Group, Spravato therapy is provided as part of a structured and closely monitored care plan. Each patient is evaluated individually to determine whether this treatment is appropriate based on their symptoms, medical history, and prior treatment experience.
Beginning a new treatment can feel like a significant decision, particularly for those who have not found relief with past approaches. The team focuses on providing clear guidance, answering questions, and supporting patients throughout the process so they understand what to expect and can move forward with confidence.
1. Initial Consultation
The first step is requesting an appointment with the Tampa office to discuss symptoms, depression history, past treatment attempts, and whether Spravato may be appropriate. The Tampa location is listed at 4710 N Habana Ave, Suite 203, Tampa, FL 33614.
2. Evaluation and Candidacy Review
During the consultation, the team reviews your mental health history, prior medication response, and treatment goals. This helps determine whether Spravato is a good next-step option for major depressive disorder or treatment-resistant depression.
3. In-Office Spravato Administration
Spravato is administered as a nasal spray in a structured, monitored clinical setting. The client’s site describes the process as carefully supervised to support patient safety and comfort throughout treatment.
4. Ongoing Treatment Schedule
The site explains that treatment typically begins with an initial phase of two sessions per week for four weeks. After that, visits often decrease to once a week and may later shift to every other week depending on the patient’s response.
5. Personalized Maintenance Plan
After the initial phase, the provider reassesses progress and tailors the treatment frequency based on ongoing needs. The practice notes that some patients continue maintenance sessions every one to two weeks, while others may benefit from longer-term maintenance care.
The Neuropsychiatry & TMS Group is an outpatient psychiatry practice with locations in Tampa, St. Petersburg, and Brandon. On its site, the practice highlights Spravato and TMS as advanced treatment options for patients whose depression has not responded well to traditional care.
The strongest brand-aligned angle for ads is that this is not a generic mental health clinic. It is a psychiatry practice offering advanced depression treatments, including Spravato, for people who need more than standard care alone.
Take the first step toward mental wellness and healing.
